Aronora is graduating from the OBI March 31, 2021, after joining the incubator in March 2013. Oregon‐based Aronora is a privately held, early clinical stage translational biopharmaceutical company engaged in the discovery, and commercial development of proprietary biological therapeutics.
Upon graduation, Aronora will relocate their lab and office from OTRADI’s incubator in the Willamette Wharf building, to a brand-new high rise downtown where they will have double the office space, a private wet lab, and conference room. In February, 2021, the Portland Business Journal listed Aronora 31st on their list of the top 37 largest bioscience and health technology companies in Oregon and SW Washington.
Shannon Heizenrader joined the OBI Mentoring Program as a Mentor in January, 2021. Shannon has a BA in Communications from Pacific Lutheran University and an MBA from Concordia University in Portland. She brings her experience in project management, as well as marketing and communications, to the mentoring relationship. Her consistency, reliability, patience, and love of learning has been a positive experience for her Mentee, who says her depth of knowledge is amazing and really helpful.
Thank you, Shannon, for being a part of the OBI Mentoring Program!
Date change! OTBC‘s Virtual Incubation Program (VIP) for rural-Oregon entrepreneurs starts its next 8 week series on April 1, 2021. VIP is for early-stage entrepreneurs who need information and advice on how to test, develop and fund their idea so they can take it from concept to the launch of a successful company. The VIP is entrepreneur education and group mentoring in an 8-week program that walks you through the process of testing your idea, starting and funding a company. Learn more about VIP and register here.
Come see the future of digital health and med-tech first hand on Wednesday, April 21 from 3-6 PM. Watch the top teams from the last fall’s OHSU Invent-a-thon make their pitch for $40,000 in funding and in-kind investor support. Network with other healthcare innovation enthusiasts in the field while the judges deliberate, and celebrate the winners. Attendance is free and open to all. Register now!
Angel Oregon Tech offers an integrated program of education on growing and financing your tech startup, peer-to-peer and investor networking, as well as the opportunity to pitch for a direct angel investment of ~$125K.
Virtual workshops will run on Thursday mornings from 9-11 AM from March 11 through April 1, 2021. Each session will feature active local investors, entrepreneurs and experts, and offer plenty of time for Q&A and community-building.
Investment-ready startups can also pitch for investment from a pool of PNW angel investors. Ten finalists will be selected to pitch at the AOTech Finale at TechFestNW on May 21, 2021.
Learn more at www.oen.org.
The challenges of 2020 have shown more than ever how important science communication is to the functioning of society. But, beyond that, it has highlighted our resilience as communicators, and the passion that we share to educate, inform, and entertain. March 24-26, 2021, connect with your community of professional science communicators at SCIENCE TALK ’21 over three days of workshops, panel discussions, presentations, and networking opportunities. Learn, explore, and share with other Science Talkers!
Stanford Drug Discovery Symposium, founded by Dr. Sanjay Malhotra from OHSU Center for Experimental Therapeutics, has become one of the highest attended events at Stanford. Every year the SDDS has the participation of leaders in the field of biomedical sciences. The speakers in this year’s symposium will include two Nobel Laureates, scientific leaders from NIH, FDA, big pharmaceutical industries and Venture Capitalist groups.
Register here for the April 19-20, 2021 symposium, free of charge.
One year after identifying the novel coronavirus that causes COVID-19, biopharmaceutical researchers have made tremendous progress toward developing safe and effective vaccines. Check out the latest on manufacturing, clinical trials and more.
Strong and reliable IP protections – including patents – have supported America’s robust innovation ecosystem by promoting discovery, development, affordability and access to new treatments and cures. As our industry continues to expand vaccine production and deliver medicines to patients in need, reliable IP protections have been critical in supporting multiple research and development and manufacturing ramp-ups on COVID-19 vaccines and therapeutics. Read why intellectual property protections are vital to research.
Virtual Lunch & Learn: Licensing and Technology Transfer
March 18, 2021
Virtual Lunch & Learn: From the Lab to the State House
Building Trust in Bioscience
March 30, 2021
Accelerate Biotech + Digital Health PDX
Virtual Happy Hour
April 1, 2021
MORE COMMUNITY & PARTNER EVENTS
TiE Oregon: Entrepreneurship and the Economy
March 16, 2021
TAO Coffee & Connection: Share Your Skills With Students
March 18, 2021
11:00 AM-12:00 PM
PSBA Lunch & Learn: Early Stage Marketing
March 24, 2021